Takeda Pharmaceutical Co TAK

NYS: TAK | ISIN: US8740602052 9/05/2024

13,37 USD (+2,37%)

(+2,37%) 9/05/2024

Toon enkel gratis nieuws

23 april 2024 · Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder · Persbericht

22 april 2024 · Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs · Persbericht

27 maart 2024 · Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE · Persbericht

25 januari 2024 · Cognizant Helping to Modernize Infrastructure and Application Management as Part of Takeda's Digital Transformation · Persbericht

22 december 2022 · Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging · Persbericht

14 september 2022 · Takeda Launches CDPATH™, a Personalized Prognostic Tool, Advancing Innovation for Patients with Crohn's Disease · Persbericht

16 juni 2021 · Takeda Pharmaceuticals Marks its 240th Founding Anniversary · Persbericht

9 juni 2021 · Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community · Persbericht

1 maart 2021 · The Children's National Hospital Rare Disease Institute And Takeda Partner To Standardize Care For Patients With Rare Diseases · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe